Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Triple-negative Breast Cancer”

631 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 631 results

Testing effectiveness (Phase 2)Study completedNCT01176669
What this trial is testing

Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Fudan University 60
Early research (Phase 1)Study completedNCT03291938
What this trial is testing

IACS-010759 in Advanced Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+22 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05522491
What this trial is testing

Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer

Who this might be right for
Solid Tumor
Hebei Medical University Fourth Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT06103864
What this trial is testing

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 625
Not applicableNot Yet RecruitingNCT06798506
What this trial is testing

Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 300
Testing effectiveness (Phase 2)Study completedNCT03121352
What this trial is testing

Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer

Who this might be right for
Metastatic Triple Negative Breast Cancer
Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT02183805
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer

Who this might be right for
Carcinoma Breast Stage IV
Sun Yat-sen University 6
Early research (Phase 1)Ended earlyNCT03579472
What this trial is testing

M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8
M.D. Anderson Cancer Center 38
Testing effectiveness (Phase 2)Ended earlyNCT05113966
What this trial is testing

Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
G1 Therapeutics, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT06162351
What this trial is testing

Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer

Who this might be right for
BreastCancer
Institut Curie 14
Testing effectiveness (Phase 2)Looking for participantsNCT06974604
What this trial is testing

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

Who this might be right for
Breast NeoplasmsLung Neoplasms
Brown University 60
Testing effectiveness (Phase 2)Looking for participantsNCT05296564
What this trial is testing

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

Who this might be right for
Sarcoma, SynovialSarcoma,Soft TissueMelanoma Stage IV+6 more
Hadassah Medical Organization 3
Testing effectiveness (Phase 2)Looking for participantsNCT07078604
What this trial is testing

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma
University of Washington 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04345913
What this trial is testing

Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma+1 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07528768
What this trial is testing

Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerMetastatic Triple-negative Breast Cancer
AntiCancer Research Jamaica 750
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Testing effectiveness (Phase 2)Ended earlyNCT01194908
What this trial is testing

Re-expression of ER in Triple Negative Breast Cancers

Who this might be right for
Breast CancerBreast TumorsBreast Neoplasms
Emory University 5
Not applicableLooking for participantsNCT07073755
What this trial is testing

Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd

Who this might be right for
Metastatic Breast CancerDrug ResistanceHormone Receptor-Positive Breast Cancer+3 more
Hunan Cancer Hospital 200
Not applicableLooking for participantsNCT07084571
What this trial is testing

Feasibility of Serial Multisite Image-guided Biopsy to Study Breast Cancer Evolution

Who this might be right for
Breast CancerMetastatic Breast CancerTriple Negative Breast Cancer
Royal Marsden NHS Foundation Trust 200
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Load More Results